17-18486005-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001040078.3(LGALS9C):āc.203A>Gā(p.Asp68Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000258 in 1,160,650 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001040078.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 117610Hom.: 0 Cov.: 16 FAILED QC
GnomAD3 exomes AF: 0.0000144 AC: 3AN: 208498Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 112162
GnomAD4 exome AF: 0.00000258 AC: 3AN: 1160650Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 578402
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 117610Hom.: 0 Cov.: 16 AF XY: 0.00 AC XY: 0AN XY: 57366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 02, 2024 | The c.203A>G (p.D68G) alteration is located in exon 3 (coding exon 3) of the LGALS9C gene. This alteration results from a A to G substitution at nucleotide position 203, causing the aspartic acid (D) at amino acid position 68 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at